NURECABSENureca Ltd· Healthcare Equipment & SuppliesHighNegative
Announced Fri, 3 Jul, 2026 · 19:13 IST

Promoter Group inter se share transfer under Family Settlement

NURECA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+0.1%Reaction day
₹229.69
prior close
—
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+0.2%-0.1% vs market
Medical Equipment & Supplies peers, median of 10sector-0.1%+0.2% vs sector

On the reaction day the stock moved 0.1 pts less than Nifty Microcap 250 and 0.2 pts more than its Medical Equipment & Supplies peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
—
10m
—
15m
—
30m
—
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+0.1+0.2-0.1-0.1+0.2
Next day
-0.7-0.5-0.2-1.7+0.9
2d
-1.9-2.5+0.6-3.1+1.2
3d
+0.4-0.6+1.0-2.4+2.7
4d
+1.9+0.7+1.1+1.1+0.8
5d
+7.5+0.9+6.6+1.1+6.4
1w
+18.0+0.5+17.5+2.6+15.4
15d
+37.5-0.2+37.8-0.6+38.1
1m
+47.0+2.9+44.2+0.0+47.0
2m
+39.7+5.0+34.7+1.4+38.3
3m
+47.2+3.7+43.5-0.9+48.0
UpDownMarket · Nifty Microcap 250Sector · Medical Equipment & Supplies peers, median of 10Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Payal Goyal from the promoter group of Nureca disclosed an off-market inter se transfer of equity shares under a Family Settlement Agreement dated 17 June 2026. Her shareholding remained unchanged at 20,59,928 shares (21.59 percent), indicating shares were reallocated among family members netting to the same total. The disclosure was made as a precaution even though not strictly required under SEBI insider trading rules.

Likely market impact

Neutral for shareholders. Internal family restructuring with no net change in promoter holding.